L-Lactic Acid → HCID 69507875, compound
Reaction equation
Cl.[C:2]([N:5]1[CH2:11][C@H:10]([NH2:12])[C:9](=[O:13])[N:8]([CH3:14])[C:7]2[CH:15]=[CH:16][CH:17]=[CH:18][C:6]1=2)(=[O:4])[CH3:3].[C:19](O)(=[O:23])[C@H:20]([CH3:22])[OH:21]>>[C:2]([N:5]1[CH2:11][C@H:10]([NH:12][C:19](=[O:23])[C@@H:20]([OH:21])[CH3:22])[C:9](=[O:13])[N:8]([CH3:14])[C:7]2[CH:15]=[CH:16][CH:17]=[CH:18][C:6]1=2)(=[O:4])[CH3:3]Participants
3
Procedure
In an analogous manner to that described in Example 53 c), the condensation of (S)-5-acetyl-3-amino-1-methyl-1,3,4,5-tetrahydro-benzo[b][1,4]diazepin-2-one hydrochloride with L-(+)-lactic acid yielded the title compound as a yellow foam; MS: m/e=306 (M+H)+.
Sources & evidence
- ORD record
- ord-ffbd8b362dd04d5d9b72798c69807c3c
- Source dataset
- uspto-grants-2007_01
- Patent number
- US07166587B2
Reaction notes
Loading…